ArticleLipids in health and disease2026
Cumulative stress hyperglycemia ratio exposure and dynamic trajectories reveal prognostic determinants of acute hyperlipidemic pancreatitis: an 5-year cohort study.
Article in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe stress hyperglycemia ratio (SHR) and glycemic variability (GV) both reflect acute glycemic fluctuations, with established roles in cardiovascular and stroke diseases. However, their prognostic value in acute hyperlipidemic pancreatitis (HTG-AP) remains underexplored. Traditional assessments based on single measurements fail to capture the dynamic evolution. Therefore, this study aims to evaluate the early predictive value of Cumulative stress hyperglycemia ratio (CumSHR) and trajectory combined with GV in patients with hyperlipidemic pancreatitis.
methodsThis study collected data from 959 patients with HTG-AP. SHR and GV were calculated using standardized formulas; CumSHR was derived from the area under the curve (AUC) based on SHR data from the 7 days prior to admission. Multivariable analyses and RCS analysis assessed whether CumSHR predicted severe hyperlipidemic acute pancreatitis (HTG-SAP). Subgroup stratification was performed based on clinically distinct glucose metabolic states, while Latent class growth mixture model (LCGMM) identified dynamic SHR trajectory sub-phenotypes. Kaplan-Meier (K-M) curves compared survival rates across different risk trajectory groups. Finally, machine learning models predicted HTG-SAP risk, and SHapley Additive exPlanations (SHAP) identified key predictors.
resultsIn the Jiangxi cohort, 162 cases (16.9%) of HTG-AP developed HTG-SAP. RCS analysis demonstrated a U-shaped association between CumSHR and HTG-SAP and persistent organ failure (POF) (P < 0.001). The LCGMM identified three dynamic trajectories: the sustained high-value group (SHG-T3) exhibited the highest risk of HTG-SAP (55.6%, compared with 10.6% in the low-value gradually decreasing group [LDG-T1]). Subsequently, stratified into normal glucose regulation (NGR), pre-diabetes Mellitus (Pre-DM), and diabetes mellitus (DM), high CumSHR + high GV showed increased risk compared to low CumSHR + low LGV (P < 0.05). Among machine learning models predicting HTG-SAP risk, the Naive-Bayes model demonstrated the highest predictive accuracy. SHAP analysis identified CumSHR as one of the most important predictors.
conclusionsThis study demonstrates that CumSHR exhibits significant association with early assessment of severe conditions in patients with HTG-AP, with its trajectory effectively capturing dynamic changes to compensate for the limitations of static prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.